Article

Bivalent RSVpreF effectiveness against RSV-related lower respiratory tract disease hospitalization and ED visits across three RSV Seasons

2026-07-13

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> RSV vaccines reduce the risk of severe outcomes such as hospitalization and emergency department (ED) visits for at least 2 RSV seasons following vaccination. No data have been published on real-world RSV vaccine effectiveness (VE) beyond the second season after vaccination. This study evaluates bivalent RSVpreF VE against RSV-related lower respiratory tract disease (LRTD)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 557847f4-412e-5dbf-85b7-9f1b0d478e16
DOI: 10.64898/2026.07.08.26357564

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bivalent RSVpreF effectiveness against RSV-related lower respiratory tract disease hospitalization and ED visits across three RSV SeasonsDOI 10.64898/2026.07.08.26357564Read

Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe InfectionSemantic proximity Read

The Effect of SARS-COV-2 Variant on Respiratory Features and Mortality Among Vaccinated and Non-Fully Vaccinated PatientsSemantic proximity Read

Altered RSV Epidemiology and Genetic Diversity Following the COVID-19 PandemicSemantic proximity Read

Epidemiological Study of Post-Pandemic Pediatric Common Respiratory Pathogens using Multiplex DetectionSemantic proximity Read

Vaccine Effectiveness of mRNA-1345 Against RSV-Associated Hospitalization and Medically Attended Acute Respiratory Illness Among US Veterans, 2025–2026Semantic proximity Read

Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort studySemantic proximity Read

Estimated incidence rate of specific cardiovascular and respiratory hospitalizations attributable to Respiratory Syncytial Virus among adults in Germany between 2015 and 2019Semantic proximity Read

Impact of respiratory syncytial virus in the United States.Semantic proximity Read

Clinical and economic burden of Respiratory Syncytial Virus in children aged 0-5 years in ItalySemantic proximity Read

Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.Semantic proximity Read

Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University HospitalSemantic proximity Read

Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023)Semantic proximity Read